Booting Earth Optimization System
Thank you for your patience. Your civilization is very important to us.
Metformin
Treatment for Chronic kidney disease due to diabetes mellitus type 2
Typical Dosage: 500-2000mg daily
Effectiveness
75%
Safety Score
65%
Clinical Trials
1,000
Participants
5M
Comparative Safety Scale(Higher is safer)
Cyanide☠️
Meth💀
Cigarettes🚬
Chemo☢️
Alcohol🍺
Morphine💊
Antibiotics💉
Tylenol💊
Exercise🏃
Water💧
65
DangerousModerateSafe
Treatment Details
Dosage Range
500-2000mg daily
Time to Effect
1-2 weeks for glycemic control, years for long-term complications
Treatment Duration
lifetime (if eGFR allows)
Evidence Quality
HIGHNumber Needed to Treat (NNT)
25(Treat 25 patients to see 1 additional successful outcome)
Number Needed to Harm (NNH)
5(Treat 5 patients to see 1 additional serious adverse event)
Confidence Score
95%confidence in effectiveness data
Health Economics
Annual Cost of Care
Drug Cost:$120
Monitoring:$1,200
Side Effect Mgmt:$50
Total Annual:$1,370
Cost-Effectiveness Analysis
Cost-Effectiveness Rating
EXCELLENTICER
$10,000/QALY
QALYs Gained
1.8
Outcome-Based Costs
Cost per Responder
$1,522.22
Metformin Outcomes
for Chronic kidney disease due to diabetes mellitus type 2
Efficacy Outcomes
Overall Effectiveness
+75%
Response Rate
+90%
Common Side Effects
Diarrhea
+20%
Nausea
+10%
Abdominal discomfort
+10%
WARNING: LIMITED TRIALS AVAILABLE
You can search for trials, but you probably can't join any because the 1% Treaty hasn't passed yet. Most trials are severely limited by lack of funding and bureaucratic barriers. Help change this!
Active Clinical Trials
No active trials currently recruiting for this treatment
No active trials found in ClinicalTrials.gov